Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Lumos Pharma reported $-8932000 in EBIT for its fiscal quarter ending in September of 2023.

Ebit Change Date
Aceragen USD -7443000 1.14M Mar/2023
Alterity Therapeutics Limited AUD -7772080 2.99M Jun/2023
Bristol-Myers Squibb USD 2.72B 194M Sep/2023
Capricor Therapeutics USD -6864600 882.66K Sep/2023
Cipla INR 14.44B 1.89B Sep/2023
Clal Biotechnology ILS -5438000 3.76M Dec/2022
Compugen USD -10628000 414K Sep/2023
CSL USD 1.03B 1.18B Jun/2023
Eli Lilly USD 3.43B 1.2B Sep/2023
Grifols EUR 243.07M 12.7M Sep/2023
Incyte USD 215.33M 13.73M Sep/2023
Merck USD 6.52B 10.93B Sep/2023
Nektar Therapeutics USD -33504000 541K Sep/2023
Pfizer USD -3149000000 5.27B Sep/2023
Sarepta Therapeutics USD -20842000 112.68M Sep/2023